S&P 500 climbs, but Nvidia slip keeps lid on gains
Johnson & Johnson Innovation - JJDC, Inc., a ten percent owner of CVRx , Inc. (NASDAQ:CVRX), sold 1,000 shares of common stock on November 12, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a weighted average price of $10.00, with individual sales prices ranging from $10.00 to $10.04, for a total transaction value of $10,000.
Following the transaction, Johnson & Johnson Innovation - JJDC, Inc. indirectly holds 4,049,898 shares of CVRx.
In other recent news, CVRx Inc. reported its third-quarter 2025 financial results, revealing a revenue of $14.7 million. This figure represents a 10% year-over-year growth and exceeded analyst expectations, including Cantor Fitzgerald’s estimate of $14.5 million and the FactSet consensus of $14.1 million. Additionally, the company’s earnings per share (EPS) showed a slight improvement, with a reported loss of $0.49 compared to the anticipated loss of $0.50. Following these results, Cantor Fitzgerald raised its price target for CVRx to $13 from $11, maintaining an Overweight rating. Similarly, Canaccord Genuity increased its price target to $11 from $9, maintaining a Buy rating on the stock. Notably, CVRx’s U.S. revenue reached $13.5 million, slightly surpassing Canaccord’s projection of $13.4 million. Despite the positive financial performance, CVRx’s stock experienced a decline in after-hours trading. These developments highlight the company’s recent financial achievements and analyst responses.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.